chr3-108559786-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_020890.3(CIP2A):c.1984C>T(p.Arg662Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000241 in 1,587,616 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 1 hom. )
Consequence
CIP2A
NM_020890.3 missense
NM_020890.3 missense
Scores
6
6
7
Clinical Significance
Conservation
PhyloP100: 5.90
Genes affected
CIP2A (HGNC:29302): (cellular inhibitor of PP2A) Enables protein homodimerization activity. Predicted to act upstream of or within positive regulation of neural precursor cell proliferation and spermatogenesis. Located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CIP2A | NM_020890.3 | c.1984C>T | p.Arg662Cys | missense_variant | 16/21 | ENST00000295746.13 | NP_065941.2 | |
CIP2A | XM_006713716.4 | c.1981C>T | p.Arg661Cys | missense_variant | 16/21 | XP_006713779.1 | ||
CIP2A | XM_011513057.3 | c.1042C>T | p.Arg348Cys | missense_variant | 9/14 | XP_011511359.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIP2A | ENST00000295746.13 | c.1984C>T | p.Arg662Cys | missense_variant | 16/21 | 1 | NM_020890.3 | ENSP00000295746.7 | ||
CIP2A | ENST00000491772.5 | c.1507C>T | p.Arg503Cys | missense_variant | 16/21 | 1 | ENSP00000419487.1 | |||
CIP2A | ENST00000481530.5 | n.*1554C>T | non_coding_transcript_exon_variant | 16/21 | 1 | ENSP00000417297.1 | ||||
CIP2A | ENST00000481530.5 | n.*1554C>T | 3_prime_UTR_variant | 16/21 | 1 | ENSP00000417297.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152116Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
20
AN:
152116
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000125 AC: 31AN: 248228Hom.: 0 AF XY: 0.000127 AC XY: 17AN XY: 134098
GnomAD3 exomes
AF:
AC:
31
AN:
248228
Hom.:
AF XY:
AC XY:
17
AN XY:
134098
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000253 AC: 363AN: 1435500Hom.: 1 Cov.: 30 AF XY: 0.000268 AC XY: 190AN XY: 709794
GnomAD4 exome
AF:
AC:
363
AN:
1435500
Hom.:
Cov.:
30
AF XY:
AC XY:
190
AN XY:
709794
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000131 AC: 20AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74286
GnomAD4 genome
AF:
AC:
20
AN:
152116
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74286
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
16
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2023 | The c.1984C>T (p.R662C) alteration is located in exon 16 (coding exon 16) of the KIAA1524 gene. This alteration results from a C to T substitution at nucleotide position 1984, causing the arginine (R) at amino acid position 662 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;.
REVEL
Uncertain
Sift
Pathogenic
D;D;.
Sift4G
Pathogenic
D;D;D
Polyphen
D;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at